tiprankstipranks
Trending News
More News >
22nd Century (XXII)
NASDAQ:XXII
US Market

22nd Century (XXII) Price & Analysis

Compare
1,806 Followers

XXII Stock Chart & Stats

$0.76
-$0.08(-1.39%)
At close: 4:00 PM EST
$0.76
-$0.08(-1.39%)

Bulls Say, Bears Say

Bulls Say
Debt-free Balance SheetBecoming debt-free and adding cash (quarter-end $4.8M plus a $9.5M insurance settlement) materially improves financial flexibility. Lower leverage reduces interest burden and bankruptcy risk, enabling management to fund VLN expansion and product investment without incremental debt over the medium term.
VLN Distribution And Product AcceptanceRapid retail roll-out to ~1,500 stores and positive taste reviews signal improving product-market fit. Sustainable retail distribution, if maintained, supports recurring branded sales and scale advantages versus contract manufacturing, improving margin prospects as volumes and brand recognition grow.
Strategic Shift To Higher-margin Branded ProductsMoving from low-margin CMO work to owned branded VLN and natural-style cigarettes targets structurally higher gross margins and better control of pricing and distribution. If execution sustains, this repositioning improves revenue mix, gross-margin potential and long-term EBITDA durability.
Bears Say
Persistent Unprofitability And Revenue DeclineDeep negative gross and net margins and TTM revenue declines indicate operation-level deficiencies that require sustained top-line growth and margin recovery. Structural losses constrain reinvestment, extend the timeline to breakeven, and mean execution risk is high absent sustained volume gains and mix improvement.
Negative Operating Cash FlowOngoing negative operating cash flow limits the company's ability to self-fund growth and absorb shocks. The small positive free cash flow growth is from a negative base, so reliance on one-time items and external financing remains likely until consistent positive OCF is achieved.
Weak Equity Base And Dilution RiskA low equity ratio and highly negative ROE (pack metrics) combined with a reverse split and amended preferred terms signal a weak capital base and high dilution risk. The company has active authorization to raise capital (up to $25M sales agreement), which may dilute shareholders and affect long-term per-share economics.

22nd Century News

XXII FAQ

What was 22nd Century’s price range in the past 12 months?
22nd Century lowest stock price was $5.18 and its highest was $1138.50 in the past 12 months.
    What is 22nd Century’s market cap?
    22nd Century’s market cap is $2.88M.
      When is 22nd Century’s upcoming earnings report date?
      22nd Century’s upcoming earnings report date is Mar 05, 2026 which is in 12 days.
        How were 22nd Century’s earnings last quarter?
        22nd Century released its earnings results on Nov 04, 2025. The company reported -$15.9 earnings per share for the quarter, beating the consensus estimate of -$251.85 by $235.95.
          Is 22nd Century overvalued?
          According to Wall Street analysts 22nd Century’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does 22nd Century pay dividends?
            22nd Century does not currently pay dividends.
            What is 22nd Century’s EPS estimate?
            22nd Century’s EPS estimate is -2.1.
              How many shares outstanding does 22nd Century have?
              22nd Century has 510,177 shares outstanding.
                What happened to 22nd Century’s price movement after its last earnings report?
                22nd Century reported an EPS of -$15.9 in its last earnings report, beating expectations of -$251.85. Following the earnings report the stock price went down -16.778%.
                  Which hedge fund is a major shareholder of 22nd Century?
                  Currently, no hedge funds are holding shares in XXII
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    22nd Century

                    22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

                    22nd Century (XXII) Earnings & Revenues

                    XXII Earnings Call

                    Q3 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call highlighted significant strategic progress and financial improvements, such as becoming debt-free and expanding higher-margin branded products. However, the company continues to face challenges with ongoing losses and a decline in revenue. While the balance sheet has strengthened, the timeline to profitability remains uncertain. The sentiment is cautiously optimistic with notable achievements but balanced by current financial challenges.View all XXII earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Universal
                    Turning Point Brands
                    Greenlane Holdings
                    Kaival Brands Innovations Group
                    Ispire Technology, Inc.

                    Ownership Overview

                    50.13%0.49%<0.01%49.37%
                    50.13% Insiders
                    <0.01% Other Institutional Investors
                    49.37% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks